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Abstract
In the frame of multicenter research studies, biobanks ensure the harmonization 
and traceability of the prospective collection of quality samples. This is significant 
because pre-analytical variables must be carefully considered to guarantee the 
integrity of biomarkers to be tested and to avoid bias affecting the validity of the 
analytical results. According to a quality management system, biobanks contribute 
with documents and records; consumable preparation for collection, processing, 
and conservation; sample quality controls; and centralized management of sample 
handling, storage, and distribution. Traceability of samples is based on unique 
standard codes and the use of pre-assigned, pre-coded, and pre-labeled materials 
for sample collection, processing, and conservation. By using these supporting 
tools, quality derivatives are obtained based on common and evidence-based 
standard operating procedures (SOPs), with associated traceability information 
in relation with their collection, processing, conservation, and distribution. The 
biobank-supported workflow, specifically designed and implemented for each 
project, allows obtaining harmonized quality samples contributing to the quality of 
large and complex research projects and the corresponding validity of the analyses.
Keywords: multicenter prospective project, sample handling, traceability, workflow 
harmonization, quality-assured biobanking
1. Introduction
Professionalism is the current hallmark of biobanks [1], which are driven by 
standards and best practices. A biobank is “an entity that receives, stores, processes, 
and/or distributes specimens, as needed. It encompasses the physical location as 
well as the full range of activities associated with its operation [2].” Different types 
of biobanks have been proposed [3], although the definitive model will be the result 
of the activities performed in support of the particular needs of attended projects, 
including real or virtual collection, processing, conservation, and distribution.
Biobanks have been involved in large quality-assured prospective studies based 
on validated and standardized sample handling and storage protocols [4, 5]. When 
a prospective multicenter research project is designed, multiple variables must be 
considered such as the number and type of donations, recruitment sites and ana-
lytical laboratory locations, pre-analytical requirements of samples and derivatives 
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obtained, and processing and storage facilities. Attending to the complexity of the 
project, a specific workflow is implemented after process definition identifying 
every factor involved in (site, staff, equipment, method, materials, samples and 
transferences) and their corresponding checkpoints.
2. Harmonization of sample collection and derivative preservation
To guarantee the integrity of biomarkers to be tested and to avoid bias, pre-ana-
lytical variables must be carefully considered [6]. In fact, many studies are being 
conducted to elucidate the effects of pre-analytical variables on analytical profiles. 
In this sense, a study has been recently published to determine acceptable delays to 
fixation for formalin-fixed paraffin-embedded (FFPE) tissue samples [7]. In order 
to mitigate their impact in the complex frame of multicenter projects, biobanks 
contribute through supervised materials and sample handling and continuous and 
overlapped checkpoints.
2.1  Centralized preparation of consumables for sample collection, processing 
and preservation
With the objective to ensure the consistency in sample collection, stabilization, 
and preservation, specific kits with the consumables necessary for only a donation 
are defined in function of pre-analytical requirements of obtaining samples and 
derivatives (Figure 1). A careful selection of collection devices is critical here since 
differences in biomarker testing have been reported [8, 9]. Consumables such as 
modified cards (IsoCode cards or FTA cards) for blood spot collection, in addition 
to multibarrier pouches with desiccant packs for room-temperature transportation 
and future conservation, could be also included for traceability purposes [10]. For 
Figure 1. 
Consumables included for sample collection, stabilization, and preservation in representative kits, classified by 
the corresponding protocol and derivatives obtained.
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noninvasive samples (nails, stool, etc.), kits targeted to donors may be designed for 
a more accessible collection at home, with the appropriate consumables to guar-
antee the integrity of samples until they are receipted by the biobank or analytical 
laboratory. When processing is performed by a different center from the recruit-
ment site, two kits are prepared in independent boxes for collection and processing, 
especially when the sample collection is made by the donor on his own.
Materials included in the kits are classified in several bags according with the 
downstream protocol. Expiration date and batch numbers for consumables must be 
considered during the purchasing process in relation with the recruitment rates and 
the validity of the results, respectively. Additionally, expiration date is identified for 
each kit according to the most recent expiration date from the consumables, and it 
is used as a reference to track and replace expired consumables by the biobank when 
the recruitment rate is not the expected.
2.2 Sample processing and quality controls
Evidence-based standard operating procedures (SOPs) are elaborated for sample 
processing taking the sample requirements provided by the testing laboratories into 
consideration. The number and volume of samples necessary for analytical assays 
and the type of derivative, anticoagulant or preservative must be identified in order 
to choose the most appropriate and approachable option of prospective collection 
of samples providing high-quality biomarkers useful for downstream applications 
[11]. Additional requirements from guides [12] or previous scientific publications 
[13] are also taken into account in relation with specific sample collection and 
derivative stabilization. Preservation delay and resources available for long-term 
storage will influence the selection of the collection device as well. In fact, room-
temperature storage alternatives have been proposed [14]. When the same sample 
allows obtaining different derivatives (i.e., blood for plasma, buffy coat, and 
RBCs), protocols will adjust the number and type of collection tubes or devices 
to minimize the quantity of sample collected from the donor. On the other hand, 
the number of aliquots of liquid samples must be set in function of the different 
analyses to be performed avoiding unnecessary freeze-thaw cycles.
These pre-analytical conditions of samples and derivatives will determine where 
each process (collection, initial sample processing, provisional cryopreservation 
of derivatives, long-term storage, testing) will be performed depending on the 
recruitment site, the biobank, and the analytical laboratory locations and facilities. 
Accordingly, transportation of samples at the corresponding temperature should be 
organized [15] following the international recommendations.
Obtaining of specific derivatives such as nucleic acid isolation may be central-
ized in the biobank or testing laboratories in order to avoid bias. In the same sense, 
reactive batches must be controlled. When possible, automation of processes must 
be implemented to avoid traceability errors and decreasing hands on time. Samples 
should be handled following validation of standard operating protocols by using 
samples not belonging to the particular project, specifically collected and approved 
for this purpose by an ethical committee.
The quality of samples must be evaluated after processing by means of a 
comprehensive analysis of quality indicators [16]. Because of the current lack of 
qualification tools for each type of derivative and pre-analytical variable, numerous 
studies are trying to identify new markers to assess the fitness-for-purpose of sam-
ples. Thus, new scores and indicators have been proposed for the quality of samples 
in relation with the impact derived from the pre-analytical phase [17–23]. In the 
same way, participation in external quality assurance (EQA) schemes like the EQA 
program developed by the International Society for Biological and Environmental 
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Repositories (ISBER) focused on sample processing and testing evaluation [24]; it is 
a highly recommended complementary tool for the internal quality control (IQC). 
Biobank collaboration through international working groups focused on standard-
ization of sample processing, and biological sample quality control will contribute 
to the implementation of the last innovations in the field as well.
2.3 Monitored storage of biological samples and distribution
In relation with sample conservation, derivatives are long-term stored in the 
most appropriate conditions to maintain their original characteristics, being very 
important for the sample stability the selection of the temperature storage [15]. 
When samples are receipted in the storage facilities, aliquots are immediately 
revised to check the shipment temperature; the number, integrity, and volume of 
each aliquot regarding the expected; and incidents reported, maintaining the cold 
chain. Racks and boxes are previously prepared to directly store the derivatives in a 
reduced and optimized space within the conservation equipment classified by the 
type of container. In addition, derivatives are preferably stored separately in differ-
ent equipment and preservation rooms as a safety measure.
So, long-term storage facilities may be located in one or more rooms or buildings 
and may even be assumed by several institutions when transportation of samples 
and temperature variations are minimized. In any case, sample handling and 
positions must be under control and restricted access. Both the preservation rooms 
and storage equipment are constantly controlled through a monitoring system 
that records critical parameters such as temperature, humidity, CO2, and O2 levels 
(where necessary) and the proper functioning of equipment (compressors, battery 
power, display) (Figure 2). The system triggers an alarm when any parameter is out 
of the established range, thus activating an emergency plan. Briefly, warnings are 
received by specifically dedicated staff available for 24 h who analyze and classify 
the failure to initiate the defined corrective actions. In case it could not be repaired, 
samples are evacuated to backup equipment.
If previous instructions are followed, samples could be preserved in good condi-
tions for a long time. However, the specific period of time will depend on the type 
of sample but, most importantly, on the biomarker to be detected by a particular 
methodology, with a range from minutes to years [15]. In this sense, fitness-for-pur-
pose procedures should be validated and established when a prospective workflow 
is designed, taking into consideration the general good practices that do allow the 
most use of samples [2, 12]. Independently, other approaches have been reviewed 
for the conservation of samples at room temperature by biobanks [25].
Figure 2. 
Representative graph of a monitoring system showing a temperature of an ultra-freezer at −80°C.
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Before sending of samples to analytical laboratories from the storage facilities, 
a checkpoint is introduced to guarantee that each aliquot is compliant with the cor-
responding study or with the necessary volume of sample to thus supplement with 
additional aliquots. Additional quality controls should be performed when incidents 
during the sample conservation occur or after a non-validated long-term storage. 
The remaining precious samples may be again received for long-term storage from 
the testing laboratories followed by a new quality control.
3. Traceability of biological samples
3.1 Electronic database
The electronic database used by biobanks allows the integral management 
of multicenter prospective projects with a maximum level of security through 
restricted access. Donors, biological samples, and associated information, as 
well as the ethical-legal documentation associated to the project, are recorded. 
In detail, the system allows an exhaustive control of collaborating centers and 
researchers, preparation of sample collection kits maintaining the traceability 
of all materials used, donor and clinical information, informed consent forms, 
ethical and scientific committees’ approvals, agreements, sample handling by 
different sites (reception, processing, storage and shipments), quality incidents, 
and even the project monitoring by using any recorded information, for example, 
the recruitment rates from each clinical site. The electronic database may be also 
connected to external databases incorporating additional information such as 
temperature information from storage equipment. So, traceability is achieved 
from all the processes.
Figure 3. 
Identification of samples and materials with structured codes and representative box map with pre-coded 
tubes.
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3.2 Identification of materials and samples
Unique standardized codes are generated by the electronic database to identify 
each donation, sample, and material included in its corresponding collection kit, 
thanks to label printing (Figure 3). Therefore, samples (and associated informa-
tion) are de-identified in compliance with applicable laws. Records included in the 
kit are also identified in relation with donations.
Commercially available pre-coded tubes are selected to prepare derivative 
aliquots so that specific pre-coded tubes are pre-assigned to each type of sample 
for a donation during the kit preparation by using the electronic database, support-
ing the traceability of samples (Figure 3). Similarly, racks for the pre-coded tubes 
included in the kits are identified as well. The process of generation of a new dona-
tion code to the positions of aliquots within the storage equipment is recorded in the 
electronic database. Code generation and identification also accompany manual or 
automated sample processing to identify the samples by using code readers.
4. Quality management system
A variety of quality standards can be implemented by laboratories, being 
requirements from ISO 9001 for the quality management system (QMS) the most 
widely used [26]. Briefly, ISO 9001 is characterized by a process-based approach 
following the plan-do-check-act cycle, not only focused on the quality of a prod-
uct or service or the satisfaction of its users but on the way to obtain them. This 
QMS involves the definition and systematic management of the processes and the 
interactions between them in order to meet the legal, regulatory, and users’ require-
ments and to achieve the expected results by continuously improving efficiency. 
Specifically for biobank activities, the ISO 20387:2018 Biotechnology-Biobanking-
General Requirements for Biobanking has been launched under which other more 
specific standards will be additionally developed [27]. Next, quality assurance tools 
related with the harmonization and traceability of samples in multicenter prospec-
tive studies are shown.
4.1 Protocols, records, and other documents
The definition of processes (strategic, key, and support) involves identifying 
every factor involved (staff, equipment, method) with the objective of describing 
them through procedures and keeping them well controlled. Strict adherence to 
procedures by each stakeholder involved in the multicenter projects is mandatory to 
avoid pre-analytical deviations. A scheme summarizing the project workflow may 
be useful to clearly represent the responsibilities of all the stakeholders (Figure 4).
Clear and schematic protocols are developed for each type of collection device 
included in the kits in order to make easier the procedure interpretation (Figure 5).  
This action is especially critical when kits are targeted to donors for collection at 
home. The protocols include associated records to be filled with pre-analytical 
information of donations or samples, to report any incident that occurred during 
collection and preservation, even rack maps as guide for derivatives aliquoting into 
the specific tubes.
After centralized derivatives are obtained, a technical report specifying the 
sample processing features is accompanied in the shipments to analytical labora-
tories. Once all the samples for a study are sent from storage facilities to analyti-
cal laboratories, a final report is prepared with the missing samples, because of 
insufficient quantity of aliquots or any incident reported, and with the remaining 
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material for the study. Transaction forms specifying the samples included are 
necessary to declare the derivative shipment to the next facility involved in the 
project workflow.
Figure 4. 
Biobank-supported workflow for sample handling.
Figure 5. 
Representative schematic protocol for derivative stabilization and preservation.
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4.2 Risk management tool
As part of the quality assurance tools, the processes of prospective sample col-
lection, stabilization and processing, conservation, and distribution in multicenter 
research studies are managed under a global approach based on risk analysis, aimed 
at preventing undesired results. Since incidents are treated in the format of correc-
tive and preventative action (CAPA) and root cause analysis (RCA) documentation, 
these records are used as reference.
So, the implementation by the biobanks of a comprehensive quality control for 
sample collection kits before shipment to recruitment sites is a result from this risk 
analysis. The potential consequences (inadequate preservation of samples due to 
inappropriate devices, containers, or additives, lower amount of derivatives for 
analysis, or loss of traceability) and costs of this process (new shipment of replace-
ment kits and time of technician dedicated to kit checking), in addition to the num-
ber of nonconforming kits detected, have been evaluated. Quality control of kits is 
performed with a checklist, and follow-up of kit preparation and shipments is made 
with a specific record. Similarly, a checklist for the recruitment sites is included to 
track the reception of kits.
In addition, a training activity for the staff from the recruitment sites is orga-
nized before initializing the donors’ recruitment to present the procedures for 
sample handling and the kit composition and usage. On the other hand, a pilot 
in a recruitment site is necessary to validate the model designed and to propose 
improvement measures.
5. Conclusions
The biobank-supported workflow, specifically designed and implemented for 
each research study, allows obtaining prospective, harmonized, and quality samples 
avoiding pre-analytical bias and contributing to the validity of the analytical 
results. Through biobanking processes and continuous and overlapped checkpoints, 
quality derivatives are obtained based on common and evidence-based standard 
operating procedures and supervised materials, with associated traceability infor-
mation in relation with their collection, processing, conservation, and distribution. 
The effective workflow established is valid for large and complex multicenter 
projects.
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